Evaluation of an Education Program to Increase Knowledge and Participation in Clinical Trials Among Racial/Ethnic and Rural Populations
NCT06112002 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78
Last updated 2025-01-28
Summary
This clinical trial evaluates a culturally tailored educational outreach intervention for increasing clinical trial knowledge, referral, and participation among racial/ethnic minority and rural populations. Clinical trials are research studies that involve people. Through clinical trials, researchers are able to determine whether new treatments are safe and effective and work better than current treatments. Clinical trials can also help find new ways to prevent and detect cancer and improve the quality of life for people during and after treatment. Recruitment and retention of underrepresented groups in clinical trials remains a challenge. Racial and ethnic minority groups bear a disproportionate burden of cancer compared with other groups yet these populations continue to be underrepresented in clinical trials. This clinical trial uses community health educators (CHEs) to facilitate individual and group education sessions to improve knowledge of what constitutes a clinical trial, the value of participating in clinical trials, and why it is important for racial/ethnic minorities to participate in clinical trials.
Conditions
- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm
Interventions
- OTHER
-
Educational Intervention
Attend an educational session
- BEHAVIORAL
-
Health Education
Receive educational materials
- OTHER
-
Survey Administration
Ancillary studies
Sponsors & Collaborators
-
Ohio State University Comprehensive Cancer Center
lead OTHER
Principal Investigators
-
Electra D Paskett, PhD · Ohio State University Comprehensive Cancer Center
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-08-15
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- United States
Study Locations
More Related Trials
-
Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer
NCT00005993 ·Status: TERMINATED ·Phase: PHASE1
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma
NCT00003632 ·Status: COMPLETED ·Phase: PHASE2
-
Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer
NCT00006225 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia
NCT00004905 ·Status: COMPLETED ·Phase: PHASE2
-
Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer
NCT00002680 ·Status: COMPLETED ·Phase: PHASE2
-
Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
NCT00005613 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
NCT00003408 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma
NCT00569309 ·Status: COMPLETED ·Phase: NA
-
Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery
NCT00006126 ·Status: WITHDRAWN ·Phase: PHASE1
-
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer
NCT00027573 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors
NCT00008125 ·Status: COMPLETED ·Phase: PHASE1
-
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
NCT00004900 ·Status: COMPLETED ·Phase: PHASE2
-
Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
NCT00742924 ·Status: COMPLETED ·Phase: PHASE1
-
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer
NCT00004135 ·Status: COMPLETED ·Phase: PHASE2
-
Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p>
NCT00025545 ·Status: COMPLETED ·Phase: PHASE2
-
Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer
NCT00062140 ·Status: COMPLETED ·Phase: PHASE1
-
Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer
NCT00011921 ·Status: UNKNOWN ·Phase: PHASE3
-
G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission
NCT00233961 ·Status: COMPLETED ·Phase: PHASE1
-
Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors
NCT00025324 ·Status: UNKNOWN ·Phase: PHASE2
-
Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
NCT00004899 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer
NCT00004061 ·Status: COMPLETED ·Phase: PHASE2
-
Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer
NCT00020176 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer
NCT00202059 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma
NCT00003552 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
NCT00822120 ·Status: COMPLETED ·Phase: PHASE2